OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update
Gülsüm Özlem Elpek
World Journal of Clinical Cases (2021) Vol. 9, Iss. 19, pp. 4890-4917
Open Access | Times Cited: 27
Gülsüm Özlem Elpek
World Journal of Clinical Cases (2021) Vol. 9, Iss. 19, pp. 4890-4917
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 34
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 34
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates
Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi Turyadi, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 120-134
Open Access | Times Cited: 12
Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi Turyadi, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 120-134
Open Access | Times Cited: 12
Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1787-1787
Open Access | Times Cited: 42
Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1787-1787
Open Access | Times Cited: 42
The role and impact of viruses on cancer development
Adolfo Contreras Rengifo, Sandra Amaya, Carolina Rodríguez‐Medina, et al.
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 170-184
Closed Access | Times Cited: 7
Adolfo Contreras Rengifo, Sandra Amaya, Carolina Rodríguez‐Medina, et al.
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 170-184
Closed Access | Times Cited: 7
Current Trends and Advancements in the Management of Hepatocellular Carcinoma
Andreas Teufel, Masatoshi Kudo, Yuquan Qian, et al.
Digestive Diseases (2024) Vol. 42, Iss. 4, pp. 349-360
Closed Access | Times Cited: 5
Andreas Teufel, Masatoshi Kudo, Yuquan Qian, et al.
Digestive Diseases (2024) Vol. 42, Iss. 4, pp. 349-360
Closed Access | Times Cited: 5
Integrating CT Radiomics and Clinical Features to Optimize TACE Technique Decision-Making in Hepatocellular Carcinoma
Max Masthoff, Maximilian Irle, Daniel Kaldewey, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 893-893
Open Access
Max Masthoff, Maximilian Irle, Daniel Kaldewey, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 893-893
Open Access
Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5
Xiulian Lin, Li Xia, Yabo Zhou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4240-4240
Open Access
Xiulian Lin, Li Xia, Yabo Zhou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4240-4240
Open Access
Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System
Elena Obrador, Rosario Salvador‐Palmer, Rafael López‐Blanch, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 8
Elena Obrador, Rosario Salvador‐Palmer, Rafael López‐Blanch, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 8
Regulatory role of microRNAs in virus-mediated inflammation
Hossein Bannazadeh Baghi, Mobina Bayat, Parisa Mehrasa, et al.
Journal of Inflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Hossein Bannazadeh Baghi, Mobina Bayat, Parisa Mehrasa, et al.
Journal of Inflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2787-2787
Open Access | Times Cited: 9
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2787-2787
Open Access | Times Cited: 9
Association of IRGM gene promoter polymorphisms with hepatitis B virus infection
Ambika Sharma, Ajay Duseja, Jyoti Parkash, et al.
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Closed Access | Times Cited: 9
Ambika Sharma, Ajay Duseja, Jyoti Parkash, et al.
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Closed Access | Times Cited: 9
Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
Fei-Yan He, Gang Chen, Rong‐Quan He, et al.
PeerJ (2022) Vol. 10, pp. e12944-e12944
Open Access | Times Cited: 6
Fei-Yan He, Gang Chen, Rong‐Quan He, et al.
PeerJ (2022) Vol. 10, pp. e12944-e12944
Open Access | Times Cited: 6
Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma
Shu-Wei Huang, Yen‐Chin Chen, Yang-Hsiang Lin, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4158-4158
Open Access | Times Cited: 7
Shu-Wei Huang, Yen‐Chin Chen, Yang-Hsiang Lin, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4158-4158
Open Access | Times Cited: 7
Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection
Jie Wu, Yu Yu, Yuzhu Dai, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Jie Wu, Yu Yu, Yuzhu Dai, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers
Teresa Catalano, Federico Selvaggi, Diana L. Esposito, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1632-1632
Open Access | Times Cited: 2
Teresa Catalano, Federico Selvaggi, Diana L. Esposito, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1632-1632
Open Access | Times Cited: 2
Computational Screening of FDA‐Approved Hepatitis C Drugs for Inhibition of VEGFR2 in Liver Cancer
Miah Roney, Abdul Rashid Issahaku, Nasir Tufail, et al.
ChemistrySelect (2024) Vol. 9, Iss. 35
Closed Access
Miah Roney, Abdul Rashid Issahaku, Nasir Tufail, et al.
ChemistrySelect (2024) Vol. 9, Iss. 35
Closed Access
Role of HCV in Hepatocellular Carcinoma
Saba Zafar, Farhat Jabeen, Aiman Sajjad
(2024), pp. 113-136
Closed Access
Saba Zafar, Farhat Jabeen, Aiman Sajjad
(2024), pp. 113-136
Closed Access
Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay Between Hepatitis B and Hepatocellular Carcinoma Related Molecular Processes in Human Liver
Giovanni Colonna
Livers (2024) Vol. 5, Iss. 1, pp. 1-1
Open Access
Giovanni Colonna
Livers (2024) Vol. 5, Iss. 1, pp. 1-1
Open Access
Genomic Relevance of FGFR2 on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
Walizeb Khan, Washaakh Ahmad, Anwar M. Hashem, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3093-3093
Open Access | Times Cited: 2
Walizeb Khan, Washaakh Ahmad, Anwar M. Hashem, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3093-3093
Open Access | Times Cited: 2
Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolin.
Qianqian Xu, Bing Gao, Xinlin Liu, et al.
PubMed (2022) Vol. 15, Iss. 5, pp. 206-214
Closed Access | Times Cited: 2
Qianqian Xu, Bing Gao, Xinlin Liu, et al.
PubMed (2022) Vol. 15, Iss. 5, pp. 206-214
Closed Access | Times Cited: 2
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis
Min Yao, Jianjun Wang, Xiyu Chen, et al.
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 3, pp. 263-269
Closed Access | Times Cited: 2
Min Yao, Jianjun Wang, Xiyu Chen, et al.
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 3, pp. 263-269
Closed Access | Times Cited: 2
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6245-6245
Open Access | Times Cited: 2
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6245-6245
Open Access | Times Cited: 2
Gingival metastasis from primary hepatocellular carcinoma: a case report
Yuan Huang, Yanqiu Bao, Dongyuan Xu, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 7
Open Access | Times Cited: 1
Yuan Huang, Yanqiu Bao, Dongyuan Xu, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 7
Open Access | Times Cited: 1
Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification
Cheng‐Hsien Huang, Tung‐Jung Huang, Yu‐Chih Lin, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1362-1362
Open Access
Cheng‐Hsien Huang, Tung‐Jung Huang, Yu‐Chih Lin, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1362-1362
Open Access
Peer Review #2 of "Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways (v0.2)"
Fei-Yan He, Gang Chen, Rong‐Quan He, et al.
(2022)
Open Access
Fei-Yan He, Gang Chen, Rong‐Quan He, et al.
(2022)
Open Access
